Cryopreserved tissue engineered mucosa. by Spoerl, Gabriele et al.
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2008:46(4): 541 (541-544) 
doi: 10.2478/v10042-008-0073-9
Introduction 
Clinical applications of engineered tissue become
more and more popular. For example tissue engineered
(TE) mucosa is used to improve the soft tissue around
dental implants. This mucosa which consists of gingi-
val keratinocytes, gingival fibroblasts and a carrier
material is used as a transplant after open vestibulo-
plasty [9]. After healing of the transplant, there is fixed
immobile mucosa on the alveolar crest where the den-
tal implants pierce the mucosa.
In order to tissue engineer such grafts enough tissue
must be cultured from a biopsy also from elder patients
using autogenous serum during the culture period e.g.
over three weeks [3,4]. Therefore, cells must multiply
and not dedifferentiate. As specific markers for differ-
entiation keratinocytes express a certain cytokeratin
pattern.
The tissue engineered transplants are prepared for
each patient individually and can not be stored because
cell proliferation and cell viability are limited. After a
culture period of approximately 60 days proliferation
of the cells ceases [3]. However, what happens when
the patient for whom a graft is just in preparation
becomes sick and the operation has to be postponed.
Knowing that there is only a certain time frame for the
cells in the transplant being proliferative, viable and
differentiated, the transplant must be preserved. The
only way to achieve this goal is cryopreservation. 
Cryopreservation of single cell suspensions are
well established, but protocols and procedures to cry-
opreserve complete tissues are not available. Hence,
the aim of this investigation was as to see whether a
cryopreserved tissue engineered human mucosa trans-
plant is viable and leads after healing to a specific tis-
sue formation at the recipient site when grafted in an
animal model.
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Abstract: Single cells suspensions used for grafting in the clinical setting may be reliably cryopreserved by established pro-
tocols. However, for tissue engineered constructs which now also get used as grafts in the clinic such established protocols
and assays which indicate graft viability and their function as graft do not exist. a) The purpose was to develop a cryopro-
tocol and an animal model to test the efficacy of tissue engineered to act as graft after cryopreservation. b) Therefore, tis-
sue engineered mucosa grafts consisting of keratinocytes and fibroblasts grown in a collagen sponge were cryopreserved
and grafted in the nude rat to test its efficacy to function as mucosa graft. At different points after cryopreservation the
mucosa was grafted into the nude rats. Healing of grafts was allowed for one or three weeks. c) Sufficient cells survived the
cryopreservation allowing for the development of epithelial-fibroblast tissue in the collagen sponge. After three weeks of
healing the formation of mucosa tissue was more complete and more collagen sponge had disappeared. d) The nude rat
model is suitable to assess the efficacy of tissue engineered mucosa to function as graft after cryopreservation. The forma-
tion of human epithelial-fibroblast tissue in vivo has to be interpreted as proof of principle that the approach of cryopreser-
vation of tissue engineered grafts is working.
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Materials and methods 
For the culture of gingival keratinocytes and fibroblasts and for the
tissue engineering of mucosa transplants, human gingival biopsies
(obtained from patients undergoing wisdom tooth removal –
Approval of the Ethic Committee Dresden University of Nr.
15022002) were micro dissected into connective tissue and epithe-
lium. Using the enzyme collagenase, the fibroblasts were dissolved
from the connective tissue and seeded as single cells. The fibrob-
lasts adhered and formed a monolayer. The epithelium was cut into
explants which were placed on the floor of the culture dishes. From
the explants gingival keratinocytes grew out. Fibroblasts were cul-
tured in DMEM, keratinocytes in DMEM and Ham F12 (1:1) both
supplemented with 10% FCS. After primary culture for approxi-
mately three weeks fibroblasts and gingival keratinocytes were
seeded in a collagen sponge to tissue engineer the human mucosa
transplants. The mucosa transplants were cultured for another
week in DMEM and Ham F 12 before cryopreservation was
applied. 
Prior to cryopreservation the culture medium of the transplant
was successively changed to a self made cryoprotective medium
(based on DMEM +5% HES and 2.5% DMSO) and incubated for
10 minutes at each medium removal. Next the transplants were
cooled down stepwise to -80°C: First cooling down to 0°C with 5
K per minute and waiting for thermodynamic equilibrium up to 20
minutes. Next cooling with the same gradient to -5°C and waiting
for thermodynamic equilibrium up to 5 minutes. During this time
additional cold is applied for rapid freezing with defined ice crys-
tal structure. Afterwards further cooling with 1 K per minute to -
80°C. After rapid thawing the transplants were twice washed by
successively adding normal cell culture medium. Then respective-
ly four transplants were either used directly or cultured for anoth-
er 24, 36 to 48 hrs. Overall 24 transplants were evaluated and four
animals were operated on. Cell counting in a transplant is not pos-
sible, therefore the cell survival is checked by fluorescence meth-
ods. The transplants were stained with a non-toxic and cell-friend-
ly fluorescence dye (DIO) marking the lipid membrane of the cells
without causing cell death.
The animal model of the nude rat used here shows no immuno-
logic response against allogenous or xenogenous transplants. The
TE mucosa transplant consisting of human cells will therefore not
be rejected and heals well. Because host and donor tissue originate
from different species the transplanted cells can be identified using
human tissue specific antibodies. The TE mucosa was transplanted
subcutaneously in a dissected pouch on the back of the rats (Fig.
1). Silicon foil is used to fix the tissue engineered mucosa grafts
and to simplify transplantation and localization of the transplanted
tissue after sacrifice of the animals. After wound closure there were
healing periods of either one week or three weeks. 
Histology and immunohistology were used to assess the suc-
cess of the transplantation and the viability and differentiation of
the cells. In particular the morphology of the formed tissue was
looked at. To identify the human cells to methods were used. 
Prior to grafting the nuclei of cells (more correct the DNA) was
labelled with BrdU. After healing and immunhistologic prepara-
tion Anti BrdU (Becton Dickinson) was applied to identify the
labelled cells. Further, human keratinocytes were identified with
antibodies to different cytokeratins in the rat tissue. 
Results and discussion
Immediately 36 hrs after cryopreservation the TE
mucosa transplants maintain some tissue formation
with fibroblasts and keratinocytes in the collagen
sponge (Fig. 2). According to the preparation tech-
nique of the TE transplant the keratinocytes are on
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Fig. 1. The tissue engineered mucosa (fortified with a silicone
sheet) is transplanted subcutaneously in a dissected pouch on the
back of the rat.
Fig. 2. Tissue engineered mucosa transplants maintain some tissue
formation with fibroblasts (F) and keratinocytes (K) in the colla-
gen sponge (CS) immediately after cryopreservation
Fig. 3. One week after transplantation and healing no proper tissue
formation is seen, however clusters of keratinocytes (K).
top and the fibroblasts mainly within the collagen
sponge.
One week after transplantation and healing no
proper tissue formation is seen any more, only some
clusters of keratinocytes (Fig. 3). The collagen
sponges are not collapsed and contain also fibroblasts.
There are BrdU labelled cells within the collagen
sponge (Fig. 4) providing evidence that cells labelled
prior to cryopreservation survive the procedure and are
integrated at the recipient site. 
Three weeks after transplantation a proper epithe-
lial fibroblast tissue had formed (Fig. 5). The collagen
sponge is condensed, keratinocytes started to form cell
layers. In the sections investigated no BrdU labelled
cells could be detected. The epithelial fibroblasts tis-
sue that has formed after a healing period of three
weeks is however not in such a mature state as seen
when TE grafts are used for covering epithelial defects
in human after a similar period of time [5]. 
There are several reports about cryopreservation of
keratinocytes cultured as cell layers or on starch or col-
lagen beats [1,8]. Other cryopreserved tissue engi-
neered constructs are pancreatic and a dermal substi-
tutes [2,6]. However, for all these cells viability and
function which ranges around approx. 60 % were
assessed only in vitro after direct thawing. The trans-
plantation of cryopreserved tissue is only described for
heart valves. They may be seeded with endothelial
cells or be without [10,11]. However, between the two
groups there were no differences in respect to change
in formation of the valve collagen matrix after a heal-
ing period of up to 42 days. To our knowledge this is
the first description that for cryopreserved tissue engi-
neered mucosa transplants – consisting of gingival
keratinocytes and fibroblasts in a collagen sponge –
the in vivo proof of function by forming a human
epithelial-fibroblast tissue after grafting was reported.  
Conclusion
In conclusion the results presented underline that the
nude rat model is suitable for the assessment of cryop-
reserved tissue to function as transplant. This means
that there is a proof of principle that a cryopreserved
tissue engineered mucosa transplant (with vital cells
after cryopreservation) can function to induce specific
tissue formation at the host site. This model will be
available to assess the effects of optimizing cryoproto-
cols and cryofacilities in respect of their in vivo out-
come.
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